Hi eaco, welcome.Whenever looking at the the markets of medical device suppliers, you have to consider that hospital purchasing agents want to deal with as few suppliers as possible for any given specialty. Company ABC may have the best stent in the world; but if Company XYZ has an OK stent and a line of balloon angioplasty catheters that the surgeons like, and also a broad line of other catheters and surgical specialty products, they will lobby very hard to buy from Company XYZ.All of the companies you have mentioned -- BSX, GDT, MDT, JNJ, and NOVT -- are great businesses with strengths in different markets. But for stents and other cardiac cath lab devices, GDT and BSX are the companies to watch. JNJ could have dominated the market if they wanted to, but they obviously blew it. MDT tried once and failed; we'll see if their next attempt will bear fruit. NOVT isn't even on the map. (Another company you might want to include in your survey is C.R. Bard Inc. (BCR).)For devices used in minimally invasive surgery, I have a feeling that the days of explosive market growth are gone. It's going to be a slugfest for the remaining players.Thanks for posting, and feel free to enlighten the rest of us Fools with the fruits of your research.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat